In lung squamous cell carcinoma, elevated expression of the CST3 gene in tumor-associated fibroblasts, an alternative source of cystatin C, is also associated with reduced responsiveness to immunotherapy and worse clinical outcomes39. Here, CST3 is linked to neoplasm.